ADHD

Nonstimulant medications play a crucial role in ADHD treatment, offering effective alternatives for patients intolerant to stimulants or at risk of misuse.

Your daily dose of the clinical news you may have missed.

ACC.24: Data showed that participants with ADHD who were prescribed stimulants were 17% more likely to develop cardiomyopathy at 1 year.

Your daily dose of the clinical news you may have missed.

The risk of cardiovascular disease increased with longer cumulative exposure to ADHD medications, peaking at 3 to 5 years of use, reported researchers.

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

COPD… nasal polyps.. gout …. dyskinesia in Parkinson Disease: here’s a brief look at new drugs for these and other disorders coming your way.

Among other findings: Shared genetic factors may account for 91% of the association between adult ADHD and binge eating.

Of the [ADHD] drug's effects he said, "It was instant; it fixed everything...All these problems that had ailed me my whole life were gone."

A new study on gender differences in ADHD-depression overlap found each ADHD symptom significantly worsened depression.

The relative risk of CV events with methylphenidate is generally low; however risk of MI may be higher in the early days after initiation.

A first-of-its-kind study applies traditional growth-charting to evaluate abnormal developmental patterns in connectivity networks of a child's brain.

Most significant were positive changes in motivation to complete mental work and in vigor, fatigue, and depression.

ADHD: seen only in kids; boys are more impaired vs girls; only stimulants work. Myths or facts?

What does ADHD look like in adults? What signs/symptoms should be on your radar? Find out what you know and what you need to know.

Attention to ADD seems to be escalating. It almost seems to be a fad. Doesn’t everyone want to be able to focus better?

Attention-deficit/hyperactivity disorder and oppositional defiant disorder are both considered disruptive behavior disorders, but the 2 disorders are distinct, having different etiologies and responding to different types of treatment.

Despite its caveats and good intentions, the AAP guideline will surely invite an inappropriate glut of medication for preschoolers . . .

About half of children with ADHD also meet the diagnostic criteria for ODD but the disorders have different etiologies and respond to different types of treatment.

In the past 15 years, there has been an increasing awareness of the syndromal persistence of attention-deficit/ hyperactivity disorder (ADHD) into adulthood.

A 9-year-old asymptomatic boy was referred to our tertiary care facility with a blood lead level (BLL) of 59 μg/dL. A diagnosis of attention deficit hyperactivity disorder, which was managed with amphetamine/dextroamphetamine, had been made when the patient was 6 years old.

CINCINNATI -- Almost 9% of U.S. children ages 8 to 15 meet standard diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD), but less than half of them receive treatment.

MONTREAL -- For children with attention-deficit hyperactivity disorder who sleep poorly, methylphenidate (Ritalin) helps make them alert when they are awake.

NEW YORK -- Most kids with attention deficit hyperactivity disorder (ADHD) get better over time with treatment, regardless of what that treatment is, according to observational follow-up of a major study.